Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Nycomed licenses new anthracycline from Anthra

Oct. 16, 1997

UroCor to copromote Zeneca urology products

Oct. 16, 1997

Schering AG discloses improved taxanes

Oct. 16, 1997

Camptothecin derivatives with potent antitumor activity prepared at P&U

Oct. 16, 1997

Millennium issued U.S. patent for human melanoma gene

Oct. 16, 1997

New immunosuppressive, anticancer compounds from Kyowa Hakko

Oct. 15, 1997

Resistance modulators prepared by Byk Gulden

Oct. 15, 1997

Mayo Clinic to collaborate in developing Dendreon's dendritic cell therapy

Oct. 15, 1997

ONYX-015 combination enters phase II; U.S. patent awarded

Oct. 15, 1997

St. Jude researchers discover new role for p53

Oct. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...